Dana B. Atkinson

Dana B. Atkinson is a seasoned professional in clinical operations, currently serving as the Director of Clinical Operations at Immunovant since April 2024. Prior experience includes roles as Director of Clinical Operations at TFF Pharmaceuticals, Inc. and Associate Director of Clinical Project Management at EQRx. Dana's background features extensive experience in oncology and rare disease management through positions at Takeda Oncology, Medpace, and Argos Therapeutics. Additionally, Dana owned and led New Directions Clinical Research, Inc. and held key positions at GlaxoSmithKline and Triangle Pharmaceuticals. Dana B. Atkinson earned a Bachelor of Science degree in Medical Technology from Lenoir-Rhyne University.